Vesta

(0)
Claimed

AI-powered diagnostic tool for predicting treatment response in bladder cancer.

Pricing Model: Not Disclosed
Updated: 06/03/2025
Employees Not Disclosed
Founded in Not Disclosed
Funding Series Series A
Funding Amount $22 Million

Vesta is a cutting-edge diagnostic tool developed by Valar Labs that utilizes AI technology to analyze solid tumors, providing physicians and patients with the ability to make informed decisions about cancer treatments. Focused initially on bladder cancer, Vesta’s AI algorithms deliver unique insights into the tumor microenvironment, predicting treatment responses and allowing for evidence-based therapy selection. By reducing uncertainty in treatment decisions, Vesta empowers patients and healthcare providers to choose the most effective therapeutic options with greater confidence.

Vesta offers actionable reports that clearly indicate the likelihood of therapeutic success, allowing patients and their families to make confident decisions based on personalized information. This pioneering diagnostic approach benefits oncologists by enhancing their ability to select optimal treatments, improve patient outcomes, and potentially revolutionize cancer care.

Pros:

  • Leverages cutting-edge AI for accurate diagnostics
  • Reduces uncertainty in treatment selection
  • Provides clear, actionable reports
  • Empowers informed decision-making

Cons:

  • Currently focuses only on bladder cancer
  • May require specific histology techniques
  • Reliant on AI accuracy

Features:

  • AI Diagnostics - Utilizes AI to interpret tumors and predict treatment responses
  • Bladder Cancer Focused - Specializes in predicting treatment success for bladder cancer

Integrations:

  • Pharmaceutical Partnerships - Integrated with pharma companies to enhance R&D
  • Biomarker Discovery - Deploys diagnostics for biomarker-associated therapies

Pricing:

  • Not Disclosed - Specific pricing information has not been provided

Implementation Timeline

Not Disclosed

Onboarding

Not Disclosed

Sandbox

No

Compliance

HIPAA

Company Stage

Series A

Buying Persona

CRO, Director, Customer Success Manager, VP

Vesta alternatives

A visual AI solution for analyzing, curating, and evaluating multimodal datasets to improve model performance.

AI-powered diagnostic tool for predicting treatment response in bladder cancer.

AI-driven platform for insurance underwriting, enhancing accuracy and transparency in risk assessments.

AI-powered spot spray robots designed to modernize agriculture by saving time, cost, and increasing profitability.

Reviews and rating

Thanks for your review!

Your feedback helps us improve our service.

Only logged in customers who have purchased this product may leave a review